Pathogenesis of HIV-1 protease inhibitor-associated partial lipodystrophy: An ultrastructural study

被引：0
|
作者：
Lloreta, J
Domingo, P
Pujol, RM
Baixeras, N
Matias-Guiu, X
Serrano, S
机构：
[1] Univ Pompeu Fabra, Barcelona, Spain
[2] Autonomous Univ Barcelona, Barcelona, Spain
[3] IMIM, IMAS, Hosp Mar, Barcelona, Spain
[4] Hosp Sant Pau, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1407
引用
收藏
页码：238A / 238A
页数：1
相关论文
共 50 条
  • [41] Protease Inhibitor-Associated QT Interval Prolongation
    Hunt, Kimberley
    Hughes, Christine A.
    Hills-Nieminen, Cara
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1544 - 1550
  • [42] HIV protease inhibitor-related lipodystrophy syndrome
    Carr, A
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S135 - S142
  • [43] Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy
    Yanovski, JA
    Miller, KD
    Kino, T
    Friedman, TC
    Chrousos, GP
    Tsigos, C
    Falloon, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06): : 1925 - 1931
  • [44] HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Fessel, W. Jeffrey
    Kaufman, David
    Towner, William
    Troia, Paolo
    Ruane, Peter
    Hellinger, James
    Shirvani, Vivian
    Zolopa, Andrew
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4253 - 4261
  • [45] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [46] Atazanavir: A novel azapeptide inhibitor of HIV-1 protease
    Wang, F
    Ross, J
    FORMULARY, 2003, 38 (12) : 691 - +
  • [47] Development of Sharkavir: A Hypothetical Inhibitor for HIV-1 Protease
    Hunt, Matthew
    Abbas, Feza
    Abbas, Lyla
    Ghali, Mina
    Ghali, Helana
    Chabbra, Alesa
    Lavin, Emily
    Sikora, Arthur
    FASEB JOURNAL, 2020, 34
  • [48] Influence of inhibitor binding on HIV-1 protease dynamics
    Ringhofer, S
    Dutzler, R
    Kallen, J
    Andrew, P
    Visser, A
    Billich, A
    Scholz, D
    Gstach, H
    Steinhauser, O
    Schreiber, H
    Auer, M
    Kungl, A
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 65 : PA309 - PA309
  • [49] The management of HIV-1 protease inhibitor pharmacokinetic interactions
    Winston, A
    Boffito, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) : 1 - 5
  • [50] THE USE OF HIV-1 PROTEASE STRUCTURE IN INHIBITOR DESIGN
    BABINE, RE
    ZHANG, N
    JURGENS, AR
    SCHOW, SR
    DESAI, PR
    JAMES, JC
    SEMMELHACK, MF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (06) : 541 - 546
12345